Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for concussion and ...
Oragenics submitted its Investigator's Brochure for ONP-002, preparing for a Phase II trial for mild traumatic brain injury. Oragenics, Inc., a biotechnology company based in Sarasota, Florida ...
Mild TBI, commonly known as a concussion ... “The submission of our Investigator’s Brochure application marks a critical step forward in advancing our clinical program for ONP-002,” said ...
Mild TBI, commonly known as a concussion ... "The submission of our Investigator's Brochure application marks a critical step forward in advancing our clinical program for ONP-002,” said Janet Huffman ...
SPARK The Midlands, based at Aston University, has hosted the SPARK Europe Showcase for investors and industry to see some of ...
traumatic brain injury, seizure disorder, and others. Registration is completely voluntary and compiles with federal health privacy regulations. “It’s free to register and you can put in as ...
The Leigh Steinberg Foundation is dedicated to advancing brain health by supporting research, raising aw Collaboration Aims to Develop First Intranasal Therapy for Mild Traumatic Brain Injury Aka ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results